| Dr Mayar Jundi, MD | |
|
900 Cooper Ave, Saginaw, MI 48602-5182 | |
| (989) 497-9395 | |
| (989) 583-7173 |
| Full Name | Dr Mayar Jundi |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 32 Years |
| Location | 900 Cooper Ave, Saginaw, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962601435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 244485 (New York) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 4301095439 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Covenant Medical Center | Saginaw, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Center Inc | 2769387778 | 380 |
News Archive
AMRI and Proteros Biostructures GmbH announced today that they have signed an agreement for a joint offering to the life sciences industry. Proteros, an expert in the field of protein crystallization and X-ray structural analysis, provides services that complement AMRI's existing drug discovery capabilities in chemistry, in vitro biology, drug metabolism and pharmacokinetics services.
Today, the National Association of Boards of Pharmacy (NABP) released its Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: July 2016.
The focus of his team was also on samples, in which the bacteria failed to respond to the agent. They discovered two types of resistance. "Spontaneous mutations can occur in the gene for dihydrofolate reductase rendering trimethoprim no longer able to attack the changed enzyme, which means it becomes ineffective," Nitsche-Schmitz explained.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
SNM has been awarded a $48,000 grant from the Agency for Healthcare Research and Quality (AHRQ) to hold a conference to develop research on the comparative effectiveness of positron emission tomography (PET) and other molecular imaging techniques. The primary emphasis will be on the diagnosis and management of cancer patients, but both cardiology and neurology questions will also be addressed.
› Verified 2 days ago
| Entity Name | Covenant Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972590412 PECOS PAC ID: 2769387778 Enrollment ID: O20031209000107 |
News Archive
AMRI and Proteros Biostructures GmbH announced today that they have signed an agreement for a joint offering to the life sciences industry. Proteros, an expert in the field of protein crystallization and X-ray structural analysis, provides services that complement AMRI's existing drug discovery capabilities in chemistry, in vitro biology, drug metabolism and pharmacokinetics services.
Today, the National Association of Boards of Pharmacy (NABP) released its Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: July 2016.
The focus of his team was also on samples, in which the bacteria failed to respond to the agent. They discovered two types of resistance. "Spontaneous mutations can occur in the gene for dihydrofolate reductase rendering trimethoprim no longer able to attack the changed enzyme, which means it becomes ineffective," Nitsche-Schmitz explained.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
SNM has been awarded a $48,000 grant from the Agency for Healthcare Research and Quality (AHRQ) to hold a conference to develop research on the comparative effectiveness of positron emission tomography (PET) and other molecular imaging techniques. The primary emphasis will be on the diagnosis and management of cancer patients, but both cardiology and neurology questions will also be addressed.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mayar Jundi, MD 1447 N Harrison St, Saginaw, MI 48602-4727 Ph: (989) 497-9395 | Dr Mayar Jundi, MD 900 Cooper Ave, Saginaw, MI 48602-5182 Ph: (989) 497-9395 |
News Archive
AMRI and Proteros Biostructures GmbH announced today that they have signed an agreement for a joint offering to the life sciences industry. Proteros, an expert in the field of protein crystallization and X-ray structural analysis, provides services that complement AMRI's existing drug discovery capabilities in chemistry, in vitro biology, drug metabolism and pharmacokinetics services.
Today, the National Association of Boards of Pharmacy (NABP) released its Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: July 2016.
The focus of his team was also on samples, in which the bacteria failed to respond to the agent. They discovered two types of resistance. "Spontaneous mutations can occur in the gene for dihydrofolate reductase rendering trimethoprim no longer able to attack the changed enzyme, which means it becomes ineffective," Nitsche-Schmitz explained.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
SNM has been awarded a $48,000 grant from the Agency for Healthcare Research and Quality (AHRQ) to hold a conference to develop research on the comparative effectiveness of positron emission tomography (PET) and other molecular imaging techniques. The primary emphasis will be on the diagnosis and management of cancer patients, but both cardiology and neurology questions will also be addressed.
› Verified 2 days ago
Jerry Xavier, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, 1100 Internal Medicine, Saginaw, MI 48602 Phone: 989-583-5826 | |
Ray Peter Mangulabnan, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3170 Hallmark Ct, Saginaw, MI 48603 Phone: 989-790-1275 Fax: 989-249-4199 | |
Shafia Beg, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6800 | |
Dr. Natasa Petreska, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-746-7500 | |
Dr. Manoj Sharma, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4884 Berl Dr, Saginaw, MI 48604 Phone: 989-497-9395 Fax: 989-497-9599 | |
Minoo Khetarpal, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1320 N Michigan Ave, Suite 4, Saginaw, MI 48602 Phone: 989-755-5500 Fax: 989-755-7860 | |
Christine I Rohr, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6800 Fax: 989-583-6915 |